Oasmia Pharmaceutical AB News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

24.08.18	Oasmia Pharmaceutical publishes the Annual Report for 2017/2018 (GlobeNewswire)
24.08.18	Notice of Annual General Meeting in Oasmia Pharmaceutical AB (GlobeNewswire)
01.08.18	Notification from Oasmia Pharmaceutical AB (GlobeNewswire)
31.07.18	Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ) (GlobeNewswire)
27.07.18	Status of the Market Authorisation Application of Apealea in the European Union (GlobeNewswire)
27.07.18	Status of Orphan designation of Apealea in the European Union (GlobeNewswire)
08.06.18	Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2017 – April 30, 2018 (GlobeNewswire)
05.06.18	Results from Oasmia Pharmaceutical’s phase III study have been presented at ASCO annual meeting (GlobeNewswire)
30.05.18	Nexttobe Extends Loan to Oasmia Pharmaceutical (GlobeNewswire)
21.05.18	Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc. (GlobeNewswire)
17.05.18	Results from Oasmia Pharmaceutical’s phase III study will be presented at ASCO annual meeting in June (GlobeNewswire)
16.05.18	Notification from Oasmia Pharmaceutical (GlobeNewswire)
08.05.18	Notification from Oasmia Pharmaceutical AB (GlobeNewswire)
02.05.18	Notification from Oasmia Pharmaceutical AB (GlobeNewswire)
24.04.18	Notification from Oasmia Pharmaceutical AB (GlobeNewswire)
19.04.18	Oasmia has completed a private placement of new convertible instruments in a total amount of SEK 26,000,000 (GlobeNewswire)
02.03.18	Oasmia Pharmaceutical AB (publ) (GlobeNewswire)
19.02.18	Oasmia Pharmaceutical’s Docecal program achieves significant development milestone (GlobeNewswire)
07.01.13	DGAP-Ad hoc: Oasmia Pharmaceutical AB (EQS Group)
17.01.11	Die Top 10 der grössten Insidertransaktionen (Dow Jones)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V